Axol Bioscience acquires Newcells ophthalmology business to expand retinal organoid portfolio
Axol Bioscience has acquired the ophthalmology business of Newcells Biotech, expanding its portfolio of induced pluripotent stem cell (iPSC)-derived retinal orga... See more
Axplora expands lyophilisation capacity at Le Mans
Axplora is investing several million euros to expand lyophilisation capacity at its Le Mans site in France, alongside appointing François Houbart as head of site.
Axplora said the expansion will add comme... See more
Polaryx Therapeutics, Inc has selected a leading contract research organization (CRO) to support its SOTERIA phase 2 basket trial, advancing the clinical development of its lead candidate, PLX-200, across multiple lysosomal storage disorders (LSDs).
The S... See more
Exdensur approved by European Commission for severe asthma and chronic rhinosinusitis with nasal polyps
GSK announced that the European Commission has approved Exdensur (depemokimab) as an add-on therapy for two indications: severe asthma with type 2 infl... See more
ViiV Healthcare highlights ultra long-acting HIV pipeline and Phase 1 data at CROI 2026
ViiV Healthcare will present new data from its long-acting and ultra long-acting HIV treatment and prevention portfolio at the Conference on Retroviruses and Opportuni... See more
